"The Therapeutic Goods Administration (TGA) has announced the initiation of targeted compliance reviews for certain listed medicines that are required to display a specific warning statement concerning persistent diarrhoea. This measure aims to ensure that consumers are adequately informed about when to seek medical advice, thereby enhancing public health safety.​ The mandated warning statement is as follows:​ "Seek medical advice if diarrhoea persists for more than: 6 hours in infants under 6 months, 12 hours in children under 3 years, 24 hours in children aged 3 to 6 years, or 48 hours in adults and children over 6 years (or words to that effect)." The TGA's compliance reviews will focus on verifying that the required warning statements are appropriately displayed on the labels of relevant listed medicines. This initiative underscores the TGA's commitment to ensuring that therapeutic goods available in the Australian market meet established safety and quality standards.​"

News Region:
Oceania
News Market:
Australia
News Tags:
Food product labelling
Labelling